A Treatment Study Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia
Status:
Recruiting
Trial end date:
2032-06-30
Target enrollment:
Participant gender:
Summary
ALLTogether collects the experience of previously successful treatment of children and young
adults, with ALL from a number of well-renowned study groups into a new master protocol,
which is both a comprehensive system for stratification and treatment of ALL in this
age-group as well as the basis for several randomised and interventional trials included in
the study-design.
Phase:
Phase 3
Details
Lead Sponsor:
Mats Heyman
Collaborators:
Aamu Pediatric Cancer Foundation Acreditar - Associação de Pais e Amigos das Crianças com Cancro Amgen Belgium Health Care Knowledge Centre Cancer Research UK Clinical Trial Center North (CTC North GmbH & Co. KG) Danish Cancer Society Danish Child Cancer Foundation Fundação Rui Osório de Castro Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany Grupo Português De Leucemias Pediátricas Karolinska Institutet NordForsk Nova Laboratories Limited Pfizer Servier The Novo Nordic Foundation The Swedish Childhood Cancer Foundation The Swedish Research Council